We’re tracking in-house compensation. Take the Law360 Survey
Click here
USA v. Tanner et al
-
April 10, 2020
A New York federal judge rejected a health-related home confinement request by the imprisoned ex-CEO of defunct pharmacy Philidor Rx Services LLC, finding Thursday that the Pennsylvania prison where he is serving time for a $9.7 million kickback scheme has no known cases of COVID-19.
-
March 23, 2020
The former CEO of defunct pharmacy Philidor Rx Services LLC who was convicted in a $9.7 million kickback scheme tied to a potential acquisition deal has asked a New York federal judge to allow him to serve the remainder of his prison term in home confinement, citing the risk of exposure to the novel coronavirus.
-
January 30, 2019
Already sentenced to forfeit nearly $10 million apiece, a former Valeant Pharmaceuticals International Inc. executive and the ex-CEO of a mail-order pharmacy were ordered by a New York federal judge on Wednesday to pay Valeant more than $11.8 million in restitution for their $9.7 million kickback scheme.
-
January 01, 2019
The coming year's white collar docket is an active one, with several large health care fraud cases set to go to trial and post-trial litigation that could shape the law in insider trading and other financial crimes and affect how companies cooperate in criminal probes.
-
October 30, 2018
A former Valeant Pharmaceuticals International Inc. executive and the ex-CEO of mail-order pharmacy Philidor Rx Services LLC were each sentenced Tuesday to a year and a day in prison for orchestrating a $9.7 million kickback scheme tied to a potential acquisition deal.
-
July 18, 2018
A New York federal judge rejected a request for a new trial for two men accused of defrauding Valeant Pharmaceuticals International Inc., saying at a Wednesday hearing that their concerns about a juror didn't rise to the level that a do-over was required.
-
June 20, 2018
Prosecutors told a New York federal court Tuesday that a former Valeant Pharmaceuticals International Inc. manager's conviction over a $9.7 million kickback plot can't be scrapped just because one of the jurors in the case didn't disclose that she was involved in a civil lawsuit, saying the exec's motion for a new trial should be denied.
-
June 06, 2018
A former Valeant Pharmaceuticals International Inc. manager awaiting sentencing for his role in a $9.7 million kickback plot has urged a Manhattan federal judge to scrap his conviction, saying one of the jurors lied to hide that she's embroiled in a lawsuit alleging she abused disabled adults at a care facility.
-
May 22, 2018
A former manager at Valeant Pharmaceuticals International Inc. and the CEO of a mail-order pharmacy whose close ties to the drugmaker led to a federal investigation were convicted by a Manhattan federal jury on Tuesday of scheming to bring about a tie-up between the companies in exchange for a $9.7 million kickback.
-
May 17, 2018
Prosecutors and two health care businessmen charged with defrauding Valeant Pharmaceuticals International Inc. out of $9.7 million when it moved to buy mail-order pharmacy Philidor Rx Services LLC made their closing arguments to a Manhattan federal jury on Thursday, advancing competing views of whether Valeant was a victim or a beneficiary of Philidor's rise.